Key points are not available for this paper at this time.
Pharmaceutical industries in most developing countries with limited resources are expected to encounter several barriers while incorporating Industry 4.0 to transform into Pharma 4.0. With limited resources, a developing country must prioritise the barriers consider their impacts, and make a resource utilization plan accordingly. In this study, We employed a hierarchical multiple criteria decision analysis (MCDM) technique to identify potential barriers to Pharma 4.0 in developing countries and examine their effects to generate a prioritisation inventory. Firstly, we extracted the likely barriers using a systematic literature study and used an expert opinion-based Delphi Method to choose the most pertinent barriers. Subsequently, we analyzed the correlation and influence of the selected barriers on each other by formulating a hierarchical multi-criteria model integrating Interpretive Structural Modelling (ISM) and the Cross-Impact Matrix Multiplication Applied to Classification (MICMAC). As an outcome, we found three distinct categories of the selected 12 barriers: Prominent (4 of 12), Influencing (5 of 12), and Resulting (3 of 12). The results of this study are intended to assist the government in developing a solid adoption strategy for Pharma 4.0 and supply chain strategists in ensuring optimum resource utilization by resolving the examined barriers during the deployment of Pharma 4.0. The study is the first of its kind to discover barriers to Pharma 4.0 adoption and create hierarchical correlations within the context of the pharmaceutical sector from the perspective of a developing country.
Zaman et al. (Wed,) studied this question.